Your session is about to expire
← Back to Search
Behavioural Intervention
Robotic Postural Intervention for Cerebral Palsy
N/A
Recruiting
Led By Sunil Agrawal, PhD
Research Sponsored by Teachers College, Columbia University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age 6-17 years
Diagnosis of Bilateral CP: diplegia, triplegia, or quadriplegia
Must not have
Ability to maintain head and upper-thorax steady for 10s during supported sitting at mid-ribs or on-lower ribs: SATCo ≥ 3-4
Cognitive capacity to follow basic verbal instructions (i.e., "do not put your hands on your lap" or "follow and reach the toy")
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 4 months
Awards & highlights
No Placebo-Only Group
Summary
This trial will compare two types of therapy for children with cerebral palsy to see which is more effective.
Who is the study for?
Children aged 6-17 with bilateral cerebral palsy (diplegia, triplegia, or quadriplegia) and moderate to severe mobility limitations (GMFCS levels III or IV). They must be able to sit with support and follow basic instructions. Excluded are those with absent head control, recent major surgeries, severe spasticity or dyskinesia, spinal deformities, or recent chemodenervation therapy.
What is being tested?
The trial is testing a robotic device called TruST against static trunk support equipment for improving postural and reaching abilities in children with cerebral palsy. The study aims to see if the motor learning intervention works better when delivered through this advanced technology.
What are the potential side effects?
Since this trial involves physical support devices rather than medication, side effects may include discomfort from using the equipment or fatigue from the exercises. There's also a small risk of injury if not used properly under supervision.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 6 and 17 years old.
Select...
I have been diagnosed with cerebral palsy affecting both sides of my body.
Select...
I need assistance with most of my daily physical activities.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I can keep my head and upper chest steady while sitting.
Select...
I can understand and follow simple instructions.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through study completion, an average of 4 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 4 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in Box and Blocks Test (BBT) after intervention
Change in Modified Functional Reach Test (mFRT) after intervention
Interventional procedure
Secondary study objectives
Change in Canadian Occupational Performance Measure (COPM) after intervention
Change in Gross Motor Function Measure-Item Set (GMFM-IS) after intervention
Change in Participation and Environment Measure - Children and Youth (PEM-CY) after intervention
+3 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Robotic Trunk-Support-Trainer (TruST)Experimental Treatment1 Intervention
Postural-reaching control intervention with TruST
Group II: Static Trunk SupportActive Control1 Intervention
Postural-reaching control intervention with Rigid Trunk Support
Find a Location
Who is running the clinical trial?
Teachers College, Columbia UniversityLead Sponsor
26 Previous Clinical Trials
5,990 Total Patients Enrolled
6 Trials studying Cerebral Palsy
290 Patients Enrolled for Cerebral Palsy
Columbia UniversityOTHER
1,498 Previous Clinical Trials
2,767,043 Total Patients Enrolled
5 Trials studying Cerebral Palsy
1,039 Patients Enrolled for Cerebral Palsy
Sunil Agrawal, PhDPrincipal InvestigatorColumbia University
1 Previous Clinical Trials
12 Total Patients Enrolled
Andrew Gordon, PhDPrincipal InvestigatorTeachers College, Columbia University
1 Previous Clinical Trials
10 Total Patients Enrolled
1 Trials studying Cerebral Palsy
10 Patients Enrolled for Cerebral Palsy
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I need assistance with most of my daily physical activities.I can sit with support from my mid-ribs to pelvis for at least 5 seconds.I can understand and follow simple instructions.I have daily seizures or epilepsy that doesn't respond to medication.I have or plan to receive muscle relaxing injections in my limbs.I haven't had any major surgeries in the last 6 months.I am between 6 and 17 years old.I can understand and follow simple instructions.I have been diagnosed with cerebral palsy affecting both sides of my body.My arms are very stiff and hard to move.I am between 6 and 17 years old.I have had spine or limb surgery within the last 6 months.I have been diagnosed with cerebral palsy affecting both sides of my body.I have severe curvature of my spine.I need assistance with most of my daily physical activities.I cannot control my head movements.You have a medical condition not related to the study drug at the time of the study.My child cannot sit or balance well due to severe involuntary movements.I can keep my head and upper chest steady while sitting.
Research Study Groups:
This trial has the following groups:- Group 1: Robotic Trunk-Support-Trainer (TruST)
- Group 2: Static Trunk Support
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.